Atrial Fibrillation Also called: AF, AFib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Biomarkers in Patients Undergoing Atrial Fibrillation Ablation

Condition:   Atrial Fibrillation
Intervention:   Procedure: Catheter Ablation
Sponsor:   Universitätsklinikum Hamburg-Eppendorf
Completed

Management of Paroxystic Atrial Fibrillation in French Intensive Care Units

Conditions:   New Onset Atrial Fibrillation;   ICU Patients
Intervention:  
Sponsors:   University Hospital, Clermont-Ferrand;   French Society of Anesthesia and Intensive Care Medecine
Recruiting

The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery

Condition:   Atrial Fibrillation
Intervention:   Procedure: Posterior left pericardiotomy
Sponsors:   Weill Medical College of Cornell University;   Catholic University of the Sacred Heart
Recruiting

DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

Conditions:   Paroxysmal Atrial Fibrillation;   Atrial Fibrillation
Interventions:   Device: DiamondTemp Ablation catheter;   Device: TactiCath Quartz Ablation catheter
Sponsor:   EPIX Therapeutics
Active, not recruiting

Dual Versus Single Shock for Cardioversion of Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Device: Double shock;   Device: Single shock
Sponsor:   University of Oklahoma
Recruiting

FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   University of Miami
Recruiting

Ivabradine for Rate Control in Permanent Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Atrial Fibrillation, Persistent
Intervention:   Drug: Ivabradine
Sponsor:   Yale University
Recruiting

AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

Conditions:   Atrial Fibrillation;   Persistent Atrial Fibrillation;   Longstanding Persistent Atrial Fibrillation
Intervention:   Device: AtriCure CryoICE & AtriClip LAA Exclusion
Sponsor:   AtriCure, Inc.
Recruiting

AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation

Condition:   Recurrent Atrial Fibrillation
Intervention:   Device: AcQMap Imaging and Mapping System
Sponsor:   Acutus Medical
Recruiting

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment Naïve Asian Patients With Non-valvular Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban (Xarelto, Bay59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Active, not recruiting

This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke

Condition:   Atrial Fibrillation
Intervention:   Drug: Dabigatran
Sponsors:   Boehringer Ingelheim;   SITS international registry, Karolinska University Hospital, Stockholm, Sweden
Active, not recruiting

Electrode Positions in Cardioverting Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Device: Anterior-posterior electrode position;   Device: Anterior-lateral electrode position
Sponsors:   University of Aarhus;   Regionshospitalet Viborg, Skive;   Randers Regional Hospital;   Regionshospitalet Horsens
Recruiting

Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures

Condition:   Persistent Atrial Fibrillation
Interventions:   Procedure: Standard PVI Ablation;   Procedure: FIRM-Guided Procedure and PVI
Sponsor:   Abbott Medical Devices
Completed

Preemptive Pharmacogenetic-guided Metoprolol Management for PostoperativeAtrial Fibrillation in Cardiac Surgery

Condition:   Post-operative Atrial Fibrillation
Intervention:   Other: Guided Metoprolol Management
Sponsor:   Vanderbilt University Medical Center
Not yet recruiting

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Condition:   Atrial Fibrillation
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Apixaban (Eliquis);   Drug: Warfarin
Sponsors:   Bayer;   Janssen, LP
Active, not recruiting

Incidence of Atrial Fibrillation in Patients With Severe Obstructive Sleep Apnea: The Reveal XT-SA Study

Conditions:   Obstructive Sleep Apnea;   Atrial Fibrillation
Intervention:   Device: Implantable Loop Recorder Insertion
Sponsors:   Queen's University;   Medtronic
Active, not recruiting

The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis

Condition:   Atrial Fibrillation
Interventions:   Drug: Dabigatran vs. Rivaroxaban;   Drug: Dabigatran vs. Apixaban
Sponsors:   Boehringer Ingelheim;   Health ResearchTx, LLC (HRTX);   inVentiv Health Clinical (iVH);   United States Department of Defense (DOD)
Completed

Comparison Between One-stop Hybrid Ablation and Thoracoscopic Surgical Ablation for Refractory Atrial Fibrillation

Condition:   Persistent Atrial Fibrillation
Interventions:   Procedure: Hybrid ablation;   Procedure: Thoracoscopic surgical ablation
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting

Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation.

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Device: THERMOCOOL SMARTTOUCH SF-5D Catheter
Sponsor:   Biosense Webster, Inc.
Completed

A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   University of California, San Diego;   Biosense Webster, Inc.
Recruiting

Medtronic Terminate AF Study

Conditions:   Persistent Atrial Fibrillation;   Longstanding Persistent Atrial Fibrillation
Interventions:   Procedure: Surgical Ablation;   Device: Cardioblate and Cryoflex hand held devices
Sponsor:   Medtronic Cardiovascular
Recruiting

Prevalence of Primary Aldosteronism in Hypertensive Patients Presenting With Atrial Flutter or Fibrillation

Conditions:   Atrial Fibrillation;   Atrial Flutter;   Aldosteronism
Intervention:  
Sponsor:   University Hospital Padova
Completed

A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)

Condition:   Non-valvular Atrial Fibrillation (NVAF)
Intervention:   Drug: Rivaroxaban (Xarelto,Bay 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Not yet recruiting

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Condition:   Ischaemic Stroke
Interventions:   Drug: Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®);   Drug: Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)
Sponsor:   University Hospital Inselspital, Berne
Recruiting

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study

Condition:   Paroxysmal Atrial Fibrillation
Intervention:  
Sponsor:   Biosense Webster, Inc.
Not yet recruiting

ABLATOR Ablation Observational Registry

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Abbott Medical Devices
Completed

Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease

Conditions:   Atrial Fibrillation;   Coronary Artery Disease;   Stable Angina;   Stable Chronic Angina
Interventions:   Drug: Edoxaban;   Drug: Single Antiplatelet Agents
Sponsors:   Gi-Byoung Nam;   CardioVascular Research Foundation, Korea
Recruiting

Safety of Terminating the Use of Aspirin After Left Atrial Appendage Closure

Condition:   Atrial Fibrillation
Intervention:   Drug: Termination of aspirin
Sponsor:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting

Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study)

Condition:   Atrial Fibrillation
Intervention:   Drug: dabigatran etexilate
Sponsors:   Ural Medical University;   Boehringer Ingelheim
Recruiting

Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation

Conditions:   Dementia;   Cognition Disorders;   Cerebral Ischemic Events
Interventions:   Drug: Dabigatran Etexilate;   Drug: Warfarin
Sponsors:   Intermountain Health Care, Inc.;   Boehringer Ingelheim
Recruiting

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation

Condition:   Cardiovascular Illnesses
Interventions:   Device: the use of the WitCard;   Other: the use of WitDisplayer
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting

A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence

Conditions:   Persistent Atrial Fibrillation;   Paroxysmal Atrial Fibrillation;   Hypertension
Interventions:   Device: Renal Artery Ablation;   Device: Cardiac Ablation
Sponsor:   Abbott Medical Devices
Completed

Oral Anticoagulation in Haemodialysis Patients

Condition:   Kidney Failure, Chronic
Interventions:   Biological: No oral anticoagulation;   Drug: Oral anticoagulation with vitamin K antagonists
Sponsor:   University Hospital, Strasbourg, France
Recruiting

Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage

Condition:   Atrial Fibrillation
Intervention:   Drug: Optison echocardiography contrast agent
Sponsor:   University of Utah
Completed

PLUG Dementia Trial

Conditions:   Atrial Fibrillation;   Dementia;   Cognitive Decline
Intervention:   Other: Questionnaire
Sponsor:   Intermountain Health Care, Inc.
Recruiting

Cryoablation System FIM/CE Mark Study

Condition:   Atrial Fibrillation
Intervention:   Device: The Cryterion Cardiac Cryoablation System
Sponsors:   Boston Scientific Corporation;   Cryterion Medical, Inc.
Recruiting

Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban)

Condition:   Heart Failure
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting

AMPLATZER™ Cardiac Plug Observational Post-Approval Study (ACP PAS China)

Condition:   Non-valvular Atrial Fibrillation (NVAF)
Intervention:   Device: AMPLATZER™ Cardiac Plug
Sponsor:   Abbott Medical Devices
Enrolling by invitation

AMPLATZER™ LAA Occluder Post Approval Study (PAS)

Conditions:   Atrial Fibrillation;   Thromboembolism;   Stroke
Intervention:   Device: AMPLATZER™ LAA Occluder
Sponsor:   Abbott Medical Devices
Recruiting

A Prospective Study on the Safety and Efficacy of Apixaban for the PReventiOn of ThromboEmbolism in Adults With Congenital HearΤ Disease and Atrial ARrhythmias

Conditions:   Congenital Heart Disease;   Atrial Fibrillation;   Thromboembolism;   Anticoagulants Causing Adverse Effects in Therapeutic Use
Intervention:   Drug: Apixaban
Sponsors:   AHEPA University Hospital;   Onassis Cardiac Surgery Centre;   Attikon Hospital;   MITERA Children's Hospital
Recruiting

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

Condition:   Post-Operative Atrial Fibrillation
Interventions:   Device: AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems;   Drug: Anticoagulation Therapy
Sponsor:   AtriCure, Inc.
Completed

Study of DU-176b Aged 80 Years or Older

Condition:   Atrial Fibrillation
Interventions:   Drug: Du-176b;   Drug: placebo
Sponsor:   Daiichi Sankyo Co., Ltd.
Recruiting

Post-Embolic Rhythm Detection With Implantable Versus External Monitoring

Conditions:   Stroke;   Atrial Fibrillation;   Arrhythmias, Cardiac
Interventions:   Device: Medtronic Reveal LINQ;   Device: Sorin Spiderflash-t
Sponsors:   University of Alberta;   University of Calgary;   Alberta Innovates Health Solutions;   Medtronic
Active, not recruiting

An Observational Study of Natural History of Cardiovascular Diseases

Conditions:   Stroke;   Heart Attack;   TIA;   Cardiovascular Diseases
Intervention:  
Sponsors:   Imperial College London;   University of Oxford;   Clinical Trial Service Unit and Epidemiological Studies Unit
Completed

This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding

Condition:   Atrial Fibrillation
Intervention:   Drug: Idarucizumab
Sponsor:   Boehringer Ingelheim
Recruiting

Assessment of Arrhythmias in Patients Undergoing Transcatheter Aortic Valve Implantation Using a Small Insertable Cardiac Monitoring Device

Condition:   Aortic Valve Stenosis
Intervention:  
Sponsor:   University Hospital Inselspital, Berne
Recruiting

Ventricular Arrhythmias After Pulmonary Vein Isolation

Conditions:   Ventricular Arrhythmias;   Atrial Fibrillation
Intervention:  
Sponsor:   Universitätsklinikum Hamburg-Eppendorf
Completed

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Research & Development, LLC
Active, not recruiting

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)

Conditions:   Atrial Fibrillation;   Venous Thromboembolism;   Heart Valve Diseases or Prosthesis
Intervention:   Drug: Anticoagulant drugs
Sponsor:   CHAD
Not yet recruiting

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin;   Drug: Antiplatelet drugs
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting

Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery

Condition:   Anemia
Interventions:   Procedure: Blood transfusion at hematocrit value less than 24%;   Procedure: Blood transfusion at hematocrit value less than 28%
Sponsor:   The Cleveland Clinic
Completed

In Vitro Diagnostic Test for DOAC in Urine

Condition:   Anticoagulant Therapy
Intervention:   Diagnostic Test: DOAC Dipstick
Sponsors:   Doasense GmbH;   Clinical Research Services, Mannheim, Germany;   Institute Medical Statistics, Medical Faculty Mannheim;   Medical Care Center Dr. Limbach and Colleagues, Heidelberg, Germany
Completed

Coffee and Real-time Atrial and Ventricular Ectopy

Conditions:   Premature Atrial Contractions;   Premature Ventricular Contractions
Interventions:   Behavioral: Start: On Caffeine;   Behavioral: Start: Off Caffeine
Sponsor:   University of California, San Francisco
Recruiting

Study of the Follow-up of Stroke Treated With Anticoagulants

Condition:   Stroke
Intervention:   Drug: Anticoagulants
Sponsor:   Centre Hospitalier Universitaire Dijon
Completed

Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease

Condition:   Pulmonary Disease, Chronic Obstructive
Intervention:   Drug: Bronchodilator Agents
Sponsor:   Università degli Studi di Ferrara
Recruiting

ReachPR Trial Resynchronization Therapy in Heart Failure Patients With Prolonged PR Interval

Conditions:   Atrioventricular Dyssynchrony;   Heart Failure
Intervention:   Device: Cardiac resynchronization therapy
Sponsor:   Maastricht University Medical Center
Recruiting

A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: No treatment given
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists

Condition:   Pulmonary Disease, Chronic Obstructive
Intervention:  
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications

Conditions:   Cardiovascular Diseases;   Adherence, Medication;   Medication Adherence;   Diabetes Mellitus;   Hypertension;   Hyperlipidemias;   Coronary Artery Disease;   Atrial Fibrillation
Intervention:   Behavioral: Nudge
Sponsors:   University of Colorado, Denver;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting

Glutamate for Metabolic Intervention in Coronary Surgery

Conditions:   Coronary Artery Bypass;   Myocardial Ischemia;   Myocardial Infarction;   Coronary Artery Disease
Interventions:   Drug: Intravenous infusion of saline;   Other: Intravenous glutamate infusion
Sponsors:   University Hospital, Linkoeping;   Region Örebro County;   Blekingesjukhuset, Karlskrona
Completed

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

Condition:   Reversal of Neuromuscular Blockade
Interventions:   Drug: Sugammadex 2 mg/kg;   Drug: Sugammadex 4 mg/kg;   Drug: Sugammadex 16 mg/kg;   Drug: Neostigmine + Glycopyrrolate
Sponsor:   Merck Sharp & Dohme Corp.
Recruiting

Essential Hypotension and Allostasis Registry

Conditions:   Blood Pressure;   Depression;   Panic Attack;   Fibromyalgia;   POTS;   Inappropriate Sinus Tachycardia;   Coronary Heart Disease;   Acute Coronary Syndrome (ACS);   Acute Myocardial Infarction (AMI);   Cerebrovascular Disease (CVD);   Transient Ischemic Attack (TIA);   Atrial Fibrillation;   Diabetes Mellitus;   Cancer;   Systolic Heart Failure;   Diastolic Heart Failure;   Chronic Fatigue Syndrome;   Syncope;   Vasovagal Syncope
Intervention:  
Sponsor:   CES University
Recruiting

Heart Function in Patients Assessed for Sleep Apnoea

Conditions:   Heart Failure With Preserved Ejection Fraction;   Sleep Disordered Breathing;   Heart Failure With Normal Ejection Fraction;   Obstructive Sleep Apnea;   Central Sleep Apnea;   Heart Failure
Intervention:  
Sponsors:   Imperial College London;   Royal Brompton & Harefield NHS Foundation Trust
Active, not recruiting

HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial

Condition:   Hip Fractures
Intervention:   Other: Accelerated medical clearance and surgery
Sponsors:   McMaster University;   Population Health Research Institute;   Hamilton Health Sciences Corporation
Active, not recruiting

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

Conditions:   Frail Elderly;   Coronary Artery Disease
Interventions:   Procedure: Off-pump coronary-artery bypass grafting;   Procedure: On-pump coronary-artery bypass grafting
Sponsors:   University of Sao Paulo General Hospital;   Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo;   Instituto de Cardiologia do Distrito Federal;   Hospital Alberto Urquiza Wanderley;   Hospital das Clínicas Samuel Libânio;   Pontifícia Universidade Católica do Paraná;   Hospital Samaritano Paulista;   Beneficência Portuguesa de São Paulo;   Hospital Samaritano Campinas;   Mount Sinai Hospital, New York
Recruiting

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

Condition:   Postpartum Hemorrhage
Intervention:   Drug: Carbetocin
Sponsor:   Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Completed

Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Aclidinium bromide;   Drug: Other COPD medication
Sponsors:   AstraZeneca;   RTI Health Solutions
Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

Conditions:   Stroke;   PFO - Patent Foramen Ovale
Intervention:   Device: PFO closure with GORE® CARDIOFORM Septal Occluder
Sponsor:   W.L.Gore & Associates
Recruiting

An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: No treatment given
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Condition:   Osteoporosis, Postmenopausal
Interventions:   Drug: Bazedoxifene;   Drug: Bisphosphonate;   Drug: Raloxifene
Sponsor:   Pfizer
Completed

Perioperative Pulmonary Monitoring in Major Emergency Surgery

Conditions:   Pulmonary Complication;   Cardiovascular Complication;   Postoperative Complications
Intervention:   Procedure: Major emergency abdominal surgery
Sponsor:   Zealand University Hospital
Recruiting

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

Conditions:   Obstructive Sleep Apnea of Adult;   Preeclampsia;   Obstetrical Complications
Interventions:   Device: Continuous Positive Airway Pressure;   Other: Sleep Hygiene Control
Sponsors:   The George Washington University Biostatistics Center;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting

Safety and Performance Aspects of CRT-DX System in Patients With Sinus Rhythm

Conditions:   Heart Failure;   Cardiac Resynchronization Therapy
Intervention:   Device: Cardiac Resynchronization Therapy (CRT)
Sponsor:   Biotronik SE & Co. KG
Recruiting

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points